Pharmaceutical company Roche: top drugs based on revenue 2015-2018

Roche is one of the top pharmaceutical companies globally. They have a variety of products and medications sold worldwide with oncology being a focus area of the company. As of 2018, Roche’s top revenue generating drug was Herceptin (trastuzumab). Herceptin is a drug used in the treatment of some types of breast cancer. The drug generated about 7 billion Swiss francs in revenue during 2018.

Roche company overview

Roche is a multinational pharmaceutical company based in Basel, Switzerland. The company has two primary divisions: diagnostics and pharmaceuticals. Roche has experienced exceptional growth in recent years which can be seen in the increasing value of their sales globally. As well as sales, Roche has experienced significant growth in their research and development (R&D) expenditures. Roche has been named a leader in global pharma in several ways but has excelled in producing and selling oncologic pharmaceuticals specifically.

Oncology

Oncology is a branch of medicine that focuses on the diagnosis and treatment of cancer. The number of new cancer drugs under development in the United States is also increasing every year with significant growth recently. Oncologics and antidiabetics are the top two drug therapy areas in the United States based on drug spending.
Welcome to Statista!

We are the global leading platform for business data from 600 industries and 50 countries.

Our 700 employees believe that facts cause big changes and promote brilliant ideas. We want to offer you the best basis for fast and effective decisions: Learn more.
Selected top drugs of pharmaceutical company Roche from 2015 to 2018, based on revenue
(in million Swiss francs)
2015201620172018
-----
-----
-----
-----
-----
-----
-----
-----
-----
-----
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Roche
Roche

All Information
in one Presentation

Roche

Everything On "Roche" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Top pharmaceutical drugs"
  • Global overview
  • Select therapy classes - global
  • U.S. overview
  • Select therapy classes - U.S.
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Statista Accounts: Access All Statistics. Starting from $588 / Year
Learn more about how Statista can support your business.